Infant Formula Safety Modernization Act of 2026 updates safety standards for infant formula.
The Infant Formula Safety Modernization Act of 2026 amends the Federal Food, Drug, and Cosmetic Act to enhance safety measures for infant formula. It mandates standardized pathogen and microorganism testing for both infant formula products and manufacturing facilities. Manufacturers must submit written notifications to the Secretary of Health and Human Services within one business day of any positive test results. The Secretary is required to develop a list of pathogens and microorganisms to be tested, including clostridium botulinum.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.